Integra F
RxNorm 999823· FERROUS FUMARATE AND POLYSACCHRIDE IRON COMPLEX AND FOLIC ACID· ORAL
Vitamin C [EPC], Nicotinic Acid [EPC] · U.S. Pharmaceutical Corporation
Indications and usage
INDICATIONS: Integra FTM is indicated for the treatment of iron deficiency anemia, and folate deficiency anemia. Integra FTM is indicated in pregnancy for the prevention and treatment of iron deficiency and to supply a maintenance dosage of folic acid.
Dosage and administration
DOSAGE AND ADMINISTRATION: Adults (persons over 12 years of age), One (1) capsule daily, between meals, or as prescribed by a physician. Do not exceed recommended dosage. Do not administer to children under the age of 12.
Warnings
WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately. WARNING: Folic acid alone is improper therapy in the treatment for pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient. PRECAUTIONS: General: Anemia is a manifestation that requires appropriate investigation to determine its cause or causes. No single regimen fits all cases and the status of the patient observed in follow-up is the final criterion for adequacy of therapy. Periodic clinical and laboratory studies are considered essential. Blood examinations including hemoglobin and hematacrit should be done at the usual intervals to make certain that therapy is adequate. Use with care in the presence of peptic ulcer, regional enteritis, and ulcerative colitis. Folic acid, especially in doses above 0.1 mg -0.4 mg daily may obscure pernicious anemia, in that hematological remission can occur while neurological manifestations remain progressive.
Contraindications
CONTRAINDICATIONS: Integra FTM is contraindicated in patients with known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. Pernicious anemia is a contraindication, as folic acid may obscure its signs and symptoms.
Pregnancy
USAGE IN PREGNANCY: Before Integra FTM is prescribed for megaloblastic anemia in pregnancy, appropriate diagnostic exclusion of Addisonian pernicious anemia, (due to faulty or blocked absorption of vitamin B12, or extrinsic factor or either a genetic, immunological or surgical basis) should be carried out.
Adverse events
Most frequently reported events (FDA FAERS). Report frequency does not imply causation.
- fatigue9
- diarrhoea8
- dyspnoea6
- nausea6
- abdominal pain5
- arthralgia4
- asthenia4
- constipation4
- death4
- decreased appetite4
- fall4
- peripheral swelling4
- weight decreased4
- white blood cell count decreased4
- dizziness3
- drug hypersensitivity3
Adverse reactions (label)
Adverse Reactions: Folic Acid: Allergic sensitizations have been reported following both oral and parenteral administration of folic acid. Ferrous Fumarate: Gastrointestinal disturbances (anorexia, nausea, diarrhea, constipation, heartburn and vomiting) occur occasionally, but are usually mild and may subside with continuation of therapy. Reducing the dose and administering it with meals will minimize these effects in the sensitive patient. Increasing fiber in the diet can relieve constipation. Iron may turn stools black. This is a harmless effect that is a result of unabsorbed iron. Although the absorption of iron is best when taken between meals, giving Integra FTM after meals may control occasional G.I. disturbances. Integra FTM is best absorbed when taken at bedtime.
KR · 한국Products in Korea (70)
- 녹십자폴산정(주)녹십자
- 녹십자폴산정(주)녹십자
- 폴다정5밀리그램(폴산)(주)다림바이오텍
- 폴다정5밀리그램(폴산)(주)다림바이오텍
- 폴다정5밀리그램(폴산)(주)다림바이오텍
- 폴다정5밀리그램(폴산)(주)다림바이오텍
- 맘스폴릭정1000마이크로그램(폴산)(주)동구바이오제약
- 맘스폴릭정1000마이크로그램(폴산)(주)동구바이오제약
- 폴가정(폴산)(주)마더스제약
- 폴가정(폴산)(주)마더스제약
- 폴스원정(폴산)(주)씨엠지제약
- 폴스원정(폴산)(주)씨엠지제약
- 폴원연질캡슐(폴산)(주)알피바이오
- 폴원연질캡슐(폴산)(주)알피바이오
- 뉴로팍스정(주)한국비엠아이
- 피엠지폴산정(주)한국피엠지제약
- 피엠지폴산정(주)한국피엠지제약
- 피엠지폴산정(주)한국피엠지제약
- 피엠지폴산정(주)한국피엠지제약
- 폴맘정(폴산)동성제약(주)
View more: Full FDA label on DailyMed →Label effective 20221108